x

Phio Pharmaceuticals Corp. (Nasdaq:PHIO)

Health Care/Life Sciences • Biotechnology
CIK 1533040
Company

Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.

Address
257 Simarano Drive
Suite 101
Marlborough, Massachusetts 01752
Employees
9
Stock Info
Close
$0.8600
Day Range
0.8010 - 0.9120
52 Week Range
0.5000 - 12.2700
Average volume
715.67K
Short Interest
65.71K (02/15/24)
% of Float Shorted
2.74%
Market Cap
$2.18M
Revenue
N/A
Net Income
-$11.48M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$8.1651
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman, President, Chief Executive Officer & CFO
Robert J Bitterman Sr., MBA
Independent Director
Patricia A Bradford CPA
Independent Director
Jonathan E Freeman PhD, MBA
Lead Independent Director
Robert L Ferrara CPA
Independent Director
Curtis A Lockshin PhD
SEC filings
DateFormEvent
20 Dec, 2024 8-K
20 Dec, 2024 424B5
19 Dec, 2024 8-K
14 Nov, 2024 10-Q
14 Nov, 2024 8-K
13 Nov, 2024 SC 13G/A
7 Nov, 2024 8-K
13 Sep, 2024 4
13 Sep, 2024 4
13 Sep, 2024 4
12 Sep, 2024 4
12 Sep, 2024 4
12 Sep, 2024 4
15 Aug, 2024 4
14 Aug, 2024 10-Q
14 Aug, 2024 8-K
9 Aug, 2024 3
5 Aug, 2024 424B3
1 Aug, 2024 8-K
1 Aug, 2024 EFFECT
30 Jul, 2024 CORRESP
29 Jul, 2024 UPLOAD
26 Jul, 2024 S-1
24 Jul, 2024 D
24 Jul, 2024 8-K
12 Jul, 2024 8-K
5 Jul, 2024 8-K
2 Jul, 2024 8-K
1 Jul, 2024 EFFECT
27 Jun, 2024 CORRESP
21 Jun, 2024 8-K
11 Jun, 2024 4
10 Jun, 2024 4
28 May, 2024 8-K
24 May, 2024 UPLOAD
20 May, 2024 RW
20 May, 2024 S-3
17 May, 2024 S-1
17 May, 2024 8-K
17 May, 2024 424B5
9 May, 2024 10-Q
9 May, 2024 8-K
8 May, 2024 DEF 14A
8 May, 2024 ARS
8 May, 2024 DEFA14A
22 Apr, 2024 PRE 14A
2 Apr, 2024 8-K
1 Apr, 2024 10-K
5 Mar, 2024 4
27 Feb, 2024 4
22 Feb, 2024 4
20 Feb, 2024 4
6 Feb, 2024 SC 13G/A
26 Jan, 2024 8-K
28 Dec, 2023 424B3
27 Dec, 2023 EFFECT
22 Dec, 2023 CORRESP
21 Dec, 2023 UPLOAD
19 Dec, 2023 D
19 Dec, 2023 S-1
8 Dec, 2023 8-K
9 Nov, 2023 10-Q
9 Nov, 2023 8-K
3 Oct, 2023 4
29 Sep, 2023 S-8
21 Aug, 2023 8-K
10 Aug, 2023 8-K
10 Aug, 2023 10-Q
26 Jul, 2023 8-K
5 Jul, 2023 4
15 Jun, 2023 4
14 Jun, 2023 UPLOAD
14 Jun, 2023 CORRESP
13 Jun, 2023 D
9 Jun, 2023 ARS
9 Jun, 2023 DEFA14A
9 Jun, 2023 DEF 14A
8 Jun, 2023 S-1
2 Jun, 2023 8-K
1 Jun, 2023 424B5
24 May, 2023 8-K
16 May, 2023 8-K
11 May, 2023 8-K
11 May, 2023 10-Q
10 May, 2023 424B3
9 May, 2023 EFFECT
5 May, 2023 UPLOAD
5 May, 2023 CORRESP
2 May, 2023 D
28 Apr, 2023 S-1
20 Apr, 2023 424B3
20 Apr, 2023 424B3
20 Apr, 2023 424B3
20 Apr, 2023 424B3
20 Apr, 2023 424B3
20 Apr, 2023 424B3
20 Apr, 2023 8-K
20 Apr, 2023 8-K
19 Apr, 2023 424B5
18 Apr, 2023 8-K
17 Apr, 2023 8-K
22 Mar, 2023 8-K
22 Mar, 2023 10-K
10 Mar, 2023 8-K
3 Mar, 2023 4
22 Feb, 2023 4
22 Feb, 2023 8-K CEO Change
22 Feb, 2023 4
22 Feb, 2023 4
22 Feb, 2023 4
22 Feb, 2023 4
22 Feb, 2023 4
22 Feb, 2023 4
17 Feb, 2023 4
13 Feb, 2023 8-K
8 Feb, 2023 SC 13G/A
25 Jan, 2023 8-K
6 Jan, 2023 8-K
21 Dec, 2022 8-K
15 Dec, 2022 4
8 Dec, 2022 4
6 Dec, 2022 4
5 Dec, 2022 4
2 Dec, 2022 DEFA14A
30 Nov, 2022 DEF 14A
29 Nov, 2022 4
28 Nov, 2022 4
23 Nov, 2022 D
16 Nov, 2022 PRE 14A
16 Nov, 2022 4
16 Nov, 2022 8-K
10 Nov, 2022 10-Q
10 Nov, 2022 8-K
3 Oct, 2022 4
29 Sep, 2022 8-K
26 Sep, 2022 4
26 Aug, 2022 8-K
12 Aug, 2022 8-K
11 Aug, 2022 10-Q
11 Aug, 2022 8-K
30 Jun, 2022 DEF 14A
30 Jun, 2022 DEFA14A
12 May, 2022 10-Q
12 May, 2022 8-K
10 May, 2022 8-K CEO Change
2 May, 2022 8-K
29 Apr, 2022 3
29 Apr, 2022 10-K/A
22 Mar, 2022 8-K
22 Mar, 2022 10-K
3 Mar, 2022 4
3 Mar, 2022 8-K
3 Mar, 2022 4
16 Feb, 2022 4
16 Feb, 2022 4
16 Feb, 2022 4
16 Feb, 2022 4
16 Feb, 2022 4
16 Feb, 2022 4
16 Feb, 2022 4
16 Feb, 2022 4
11 Feb, 2022 SC 13G/A
20 Jan, 2022 SC 13G/A
21 Dec, 2021 25-NSE
10 Nov, 2021 8-K
10 Nov, 2021 10-Q
17 Aug, 2021 4
12 Aug, 2021 10-Q
12 Aug, 2021 8-K
21 Jun, 2021 8-K
21 May, 2021 EFFECT
19 May, 2021 CORRESP
19 May, 2021 UPLOAD
13 May, 2021 S-3
13 May, 2021 8-K
13 May, 2021 10-Q
6 May, 2021 DEFA14A
30 Apr, 2021 DEF 14A
25 Mar, 2021 8-K
25 Mar, 2021 10-K
5 Mar, 2021 4
3 Mar, 2021 4
3 Mar, 2021 4
3 Mar, 2021 4
3 Mar, 2021 4
3 Mar, 2021 4
3 Mar, 2021 4
3 Mar, 2021 4
3 Mar, 2021 4
19 Feb, 2021 SC 13G
17 Feb, 2021 8-K
17 Feb, 2021 424B5
16 Feb, 2021 SC 13G/A
16 Feb, 2021 D
9 Feb, 2021 424B2
8 Feb, 2021 EFFECT
5 Feb, 2021 CORRESP
4 Feb, 2021 S-3/A
2 Feb, 2021 UPLOAD
29 Jan, 2021 S-3
29 Jan, 2021 SC 13G/A
25 Jan, 2021 8-K
5 Jan, 2021 SC 13G/A
Last update:2024-03-06 12:56:34.732499
Phio Pharmaceuticals Corp. by TradingView

Sign Up to Subscribe